SCHEMBL10814378

SCHEMBL10814378

CCCCCOC(=O)OCCCOC(OC(=O)OCCCCC)n1cnc2c(NC)ncnc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 2/20 0.43
▸ CDK1 P06493 2/20 0.43
▸ CCNB1 P14635 2/20 0.43
▸ CCNB3 Q8WWL7 2/20 0.43
▸ P2RY1 P47900 2/20 0.38
▸ YTHDC1 Q96MU7 2/20 0.37
▸ ADORA3 P0DMS8 2/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ ADA P00813 4/20 0.35
▸ PDE2A O00408 3/20 0.35
▸ PDE4A P27815 2/20 0.35
▸ PDE4B Q07343 2/20 0.35
▸ PDE4C Q08493 2/20 0.35
▸ PDE4D Q08499 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10816711 0.84 CYP1A2 (0.37) CCNB2CDK1CCNB1CCNB3ADA
SCHEMBL10816337 0.84 CYP1A2 (0.43) CCNB2CDK1CCNB1CCNB3ADA
SCHEMBL10817431 0.83 ADA (0.47) ADORA1ADAPDE2APDE4APDE4B
SCHEMBL10816683 0.82 ADORA3 (0.40) CCNB2CDK1CCNB1CCNB3P2RY1
SCHEMBL9584828 0.79 CCNB2 (0.40) CCNB2CDK1CCNB1CCNB3P2RY1
SCHEMBL10814386 0.77 P2RY1 (0.46) CCNB2CDK1CCNB1CCNB3P2RY1
SCHEMBL10813829 0.77 ADORA2A (0.45) ADORA1ADAPDE2APDE4APDE4B
SCHEMBL10815977 0.77 CDK5 (0.35) —
SCHEMBL10818029 0.75 HDAC1 (0.42) CDK1YTHDC1ADORA3ADORA1
SCHEMBL10814393 0.74 HK1 (0.39) CDK1CCNB1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
US-4609661-A HERPES VIRUS SYNTEX (U.S.A.) INC. (US) 1986-09-02 — — US disclosed
US-4556659-A Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1985-12-03 — — US disclosed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP disclosed
Send feedback